MetaADEDB 2.0 @ LMMD
Lasofoxifene
(GXESHMAMLJKROZ-IAPPQJPRSA-N)
Structure
SMILES
Oc1ccc2c(c1)CC[C@@H]([C@@H]2c1ccc(cc1)OCCN1CCCC1)c1ccccc1
Type(s)
Approved; Investigational
ATC code(s)
G03XC03
Molecular Formula:
C28H31NO2
Molecular Weight:
413.551
Log P:
5.6666
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
32.7
CAS Number(s):
180915-78-0; 180916-16-9
Synonym(s)
1.
Lasofoxifene
2.
(-)-cis-5,6,7,8-tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol
3.
CP 336156
4.
CP-336,156
5.
LAS estrogen receptor modulator
6.
cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene, tartrate salt
7.
lasofoxifene hydrochloride
External Link(s)
MeSHC111332
PubChem Compound216416
BindingDB20606
CHEMBLCHEMBL328190
DrugBankDB06202
IUPHAR/BPS Guide to PHARMACOLOGY7542
KEGGdr:D04672
Therapeutic Target DatabaseD09NMD
D0Y4FA
ZINC3918428
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
15'nucleotidase increasedSIDER
2Abdominal PainSIDER
3Abdominal discomfortSIDER
4Abdominal tendernessSIDER
5Adnexa uteri cystSIDER
6Adnexa uteri massSIDER
7Alanine Aminotransferase IncreasedSIDER
8AlopeciaSIDER
9AmnesiaSIDER
10Anal FissureSIDER
11Anal spasmSIDER
12AngioedemaSIDER
13AnorexiaSIDER
14Aortic AneurysmSIDER
15AphakiaSIDER
16ArthritisSIDER
17ArthropathySIDER
18Aspartate Aminotransferase IncreasedSIDER
19AstheniaSIDER
20AuraSIDER
21Back PainSIDER
22Blood albumin decreasedSIDER
23Blood and lymphatic system disordersSIDER
24Blood creatinine abnormalSIDER
25Blood glucose increasedSIDER
26Blood triglycerides increasedSIDER
27Blood urine presentSIDER
28Bone density decreasedSIDER
29Breast engorgementSIDER
30Breast fibromaSIDER
31Bronchial HyperreactivitySIDER
32BronchitisSIDER
33Burning sensationSIDER
34BursitisSIDER
35CardiomegalySIDER
36CellulitisSIDER
37Cerebral InfarctionSIDER
38Cervical dysplasiaSIDER
39Cervical polypSIDER
40CheilitisSIDER
41CheilosisSIDER
42Chest PainSIDER
43Chest discomfortSIDER
44CholecystitisSIDER
45CholelithiasisSIDER
46ClubbingSIDER
47ConstipationSIDER
48Cor pulmonaleSIDER
49Cyclothymic DisorderSIDER
50CystoceleSIDER
51CystSIDER
52DactylitisSIDER
53Deep Vein ThrombosisSIDER
54Diabetes MellitusSIDER
55DiverticulitisSIDER
56Dry skinSIDER
57Duodenal UlcerSIDER
58DuodenitisSIDER
59DysgeusiaSIDER
60Ear and labyrinth disordersSIDER
61Ear discomfortSIDER
62EmbolismSIDER
63Endometrial HyperplasiaSIDER
64Endometrial disorderSIDER
65Endometrial hypertrophySIDER
66EndophthalmitisSIDER
67EpilepsySIDER
68ErythemaSIDER
69ExcoriationSIDER
70Extremity contractureSIDER
71FatigueSIDER
72FlatulenceSIDER
73FlushingSIDER
74Gamma-Glutamyltransferase IncreasedSIDER
75GastritisSIDER
76Gastrointestinal PainSIDER
77Genital dischargeSIDER
78Genital injurySIDER
79HeadacheSIDER
80Hepatitis B surface antigen positiveSIDER
81HepatitisSIDER
82HydrocephalusSIDER
83HydrometraSIDER
84HypercalciuriaSIDER
85HyperparathyroidismSIDER
86HypogeusiaSIDER
87ImpetigoSIDER
88InfectionSIDER
89InfestationSIDER
90InflammationSIDER
91Intermittent ClaudicationSIDER
92Irritable Bowel SyndromeSIDER
93Joint stiffnessSIDER
94Keratoconjunctivitis SiccaSIDER
95LabyrinthitisSIDER
96Limb injurySIDER
97Low density lipoprotein increasedSIDER
98LymphostasisSIDER
99Macular degenerationSIDER
100MalnutritionSIDER
101Memory impairmentSIDER
102MetrorrhagiaSIDER
103Musculoskeletal discomfortSIDER
104Neck PainSIDER
105NephrosclerosisSIDER
106Nerve injurySIDER
107Night sweatsSIDER
108NocturiaSIDER
109OnychoclasisSIDER
110Oral painSIDER
111Osteoporosis22642258CTD
112PainSIDER
113PalpitationsSIDER
114ParesisSIDER
115Pedal pulse decreasedSIDER
116PeriarthritisSIDER
117Perineal injurySIDER
118PhlebitisSIDER
119PlasmacytomaSIDER
120PresyncopeSIDER
121ProctocolitisSIDER
122PrurigoSIDER
123PruritusSIDER
124Pulmonary EmbolismSIDER
125Pulmonary granulomaSIDER
126PyelonephritisSIDER
127PyometraSIDER
128Rectal polypSIDER
129RectoceleSIDER
130Restless Legs SyndromeSIDER
131Retinal DetachmentSIDER
132Retinal Vascular DisorderSIDER
133Rheumatoid ArthritisSIDER
134RosaceaSIDER
135Rotator cuff syndromeSIDER
136SciaticaSIDER
137Skeletal injurySIDER
138Skin irritationSIDER
139Skin lesionSIDER
140StomatitisSIDER
141TachycardiaSIDER
142TenosynovitisSIDER
143TetanySIDER
144Therapeutic response unexpectedSIDER
145Thoracic vertebral fractureSIDER
146ThrombocytopeniaSIDER
147ThrombophlebitisSIDER
148ThrombosisSIDER
149Transaminases increasedSIDER
150Ultrasound breast abnormalSIDER
151Ultrasound ovary abnormalSIDER
152Upset stomachSIDER
153Urinary IncontinenceSIDER
154Urinary bladder polypSIDER
155Urinary tract infectionSIDER
156UrticariaSIDER
157Uterine PolypSIDER
158Uterine ProlapseSIDER
159Vaginal DischargeSIDER
160Vaginal Diseases16837883CTD
161Vaginal ProlapseSIDER
162Vaginal erosionSIDER
163Vaginal painSIDER
164Vaginal wall congestionSIDER
165Vascular stenosisSIDER
166Venous InsufficiencySIDER
167Venous ThrombosisSIDER
168Venous thrombosis limbSIDER
169Visual ImpairmentSIDER
170Visual disturbanceSIDER
171Vulvovaginal mycotic infectionSIDER
172Vulvovaginal painSIDER
173Vulvovaginal pruritusSIDER
174VulvovaginitisSIDER
175fibromaSIDER
176furuncleSIDER
177jaundiceSIDER
178nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.